fusaric acid has been researched along with Esophageal Neoplasms in 1 studies
Fusaric Acid: A picolinic acid derivative isolated from various Fusarium species. It has been proposed for a variety of therapeutic applications but is primarily used as a research tool. Its mechanisms of action are poorly understood. It probably inhibits DOPAMINE BETA-HYDROXYLASE, the enzyme that converts dopamine to norepinephrine. It may also have other actions, including the inhibition of cell proliferation and DNA synthesis.
Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Devnarain, N | 1 |
| Tiloke, C | 1 |
| Nagiah, S | 1 |
| Chuturgoon, AA | 1 |
1 other study available for fusaric acid and Esophageal Neoplasms
| Article | Year |
|---|---|
Fusaric acid induces oxidative stress and apoptosis in human cancerous oesophageal SNO cells.
Topics: Adenosine Triphosphate; Apoptosis; Benzimidazoles; Blotting, Western; Caspases; Cell Line, Tumor; Ce | 2017 |